Table 2.
Baseline characteristics of female AMI patients in total and by three 6-year time periods: categorical variables are displayed as total numbers (%).
| Total sample: n = 2623 | 2000–2005: n = 923 | 2006–2011: n = 886 | 2012–2017: n = 814 | p-Value | n | |
|---|---|---|---|---|---|---|
| Age at AMI | 63.33 (9.16) | 63.82 (8.73) | 63.63 (9.13) | 62.45 (9.59) | 0.004 | 2623 |
| Total deaths | 910 (34.7%) | 471 (51.0%) | 312 (35.2%) | 127 (15.6%) | <0.001 | 2623 |
| 28-days-mortality | 173 (6.6%) | 68 (7.4%) | 64 (7.2%) | 41 (5.0%) | 0.097 | 2623 |
| CVD-mortality | 537 (20.5%) | 293 (31.7%) | 176 (19.9%) | 68 (8.4%) | <0.001 | 2623 |
| Ischemic heart disease-mortality | 416 (15.9%) | 227 (24.6%) | 134 (15.1%) | 55 (6.8%) | <0.001 | 2623 |
| Cancer-mortality | 126 (4.8%) | 56 (6.1%) | 51 (5.8%) | 19 (2.3%) | <0.001 | 2623 |
| Type of infarction | 0.184 | 2623 | ||||
| STEMI | 939 (35,8%) | 347 (37.6%) | 316 (35.7%) | 276 (33.9%) | ||
| NSTEMI | 1415 (53.9%) | 493 (53.4%) | 479 (54.1%) | 443 (54.4%) | ||
| Bundle branch block | 158 (6.0%) | 46 (5.0%) | 61 (6.9%) | 51 (6.3%) | ||
| Not defined | 111 (4.2%) | 37 (4.0%) | 30 (3.4%) | 44 (5.4%) | ||
| Invasive treatment | ||||||
| CABG | 320 (12.2%) | 136 (14.7%) | 105 (11.9%) | 79 (9.7%) | 0.018 | 2623 |
| PCI | 1669 (63.6%) | 463 (50.2%) | 601 (67.8%) | 605 (74.3%) | <0.001 | 2623 |
| Prehospital time in minutes | 165.00 (90.00–511.00) | 174.00 (95.00–424.00) | 162.50 (90.00–473.25) | 163.00 (84.25–639.00) | 0.720 | 1931 |
| BMI (kg/m2) | 27.97 (5.94) | 27.71 (5.40) | 27.94 (5.97) | 28.28 (6.43) | 0.165 | 2399 |
| Hypertension | 2083 (79.4%) | 757 (82.0%) | 703 (79.3%) | 623 (76.5%) | 0.039 | 2623 |
| Diabetes mellitus | 907 (34.6%) | 344 (37.3%) | 301 (34.0%) | 262 (32.2%) | 0.131 | 2623 |
| Previous infarction | <0.001 | 2623 | ||||
| Yes | 188 (7.2%) | 105 (11.4%) | 53 (6.0%) | 30 (3.7%) | ||
| No | 2432 (92.7%) | 816 (88.4%) | 832 (93.9%) | 784 (96.3%) | ||
| No information | 3 (0.1%) | 2 (0.2%) | 1 (0.1%) | 0 (0.0%) | ||
| Previous stroke | <0.001 | 2623 | ||||
| Yes | 195 (7.4%) | 94 (10.2%) | 49 (5.5%) | 52 (6.4%) | ||
| No | 2241 (85.4%) | 707 (76.6%) | 782 (88.3%) | 752 (92.4%) | ||
| No information | 187 (7.1%) | 122 (13.2%) | 55 (6.2%) | 10 (1.2%) | ||
| Smoking status | <0.001 | |||||
| Current smoker | 821 (31.3%) | 229 (24.8%) | 304 (34.3%) | 288 (35.4%) | 2623 | |
| Ex-smoker | 443 (16.9%) | 138 (15.0%) | 129 (14.6%) | 176 (21.6%) | ||
| Never-smoker | 1008 (38.4%) | 390 (42.3%) | 329 (37.1%) | 289 (35.5%) | ||
| No information | 351 (13.4%) | 166 (18.0%) | 124 (14.0%) | 61 (7.5%) | ||
| LVEF | <0.001 | 2623 | ||||
| ≤30% | 113 (4.3%) | 37 (4.0%) | 37 (4.2%) | 39 (4.8%) | ||
| >30% | 1823 (69.5%) | 519 (56.2%) | 604 (68.2%) | 700 (86.0%) | ||
| No information | 687 (26.2%) | 369 (39.7%) | 245 (27.7%) | 75 (9.2%) | ||
| Laboratory values | ||||||
| Admission troponin I (ng/ml) | 0.51 (0.12–3.30) | 0.46 (0.12–2.60) | 0.57 (0.12–4.25) | 0.47 (0.09–3.09) | 0.277 | 1668 |
| Peak CKMB levels (U/l) | 50.00 (21.00–135.50) | 32.00 (12.00–94.00) | 52.00 (22.00–141.75) | 77.00 (36.00–185.50) | <0.001 | 2244 |
| Admission CRP (mg/dl) | 0.51 (0.29–1.50) | 0.49 (0.23–1.37) | 0.61 (0.29–1.79) | 0.49 (0.29–1.45) | <0.001 | 2438 |
| Peak glucose (mg/dl) | 156.00 (125.00–220.00) | 167.00 (130.00–256.25) | 155.50 (125.00–214.75) | 146.00 (118.00–198.00) | <0.001 | 2552 |
| eGFR (mL/min/1.73 m2) | 71.98 (55.17–90.02) | — | 68.82 (51.64–88.30) | 74.70 (58.09–91.39) | <0.001 | 1655 |
Numeric data is presented as mean (SD) or median (IQR).